These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 12592365

  • 1. CpG methylation of MGMT and hMLH1 promoter in hepatocellular carcinoma associated with hepatitis viral infection.
    Matsukura S, Soejima H, Nakagawachi T, Yakushiji H, Ogawa A, Fukuhara M, Miyazaki K, Nakabeppu Y, Sekiguchi M, Mukai T.
    Br J Cancer; 2003 Feb 24; 88(4):521-9. PubMed ID: 12592365
    [Abstract] [Full Text] [Related]

  • 2. Promoter methylation status of the DNA repair genes hMLH1 and MGMT in gastric carcinoma and metaplastic mucosa.
    Oue N, Sentani K, Yokozaki H, Kitadai Y, Ito R, Yasui W.
    Pathobiology; 2001 Feb 24; 69(3):143-9. PubMed ID: 11872960
    [Abstract] [Full Text] [Related]

  • 3. Mutually exclusive promoter hypermethylation patterns of hMLH1 and O6-methylguanine DNA methyltransferase in colorectal cancer.
    Fox EJ, Leahy DT, Geraghty R, Mulcahy HE, Fennelly D, Hyland JM, O'Donoghue DP, Sheahan K.
    J Mol Diagn; 2006 Feb 24; 8(1):68-75. PubMed ID: 16436636
    [Abstract] [Full Text] [Related]

  • 4. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z, Zhang H, Yang J, Hao T, Li S.
    Cell Biol Int; 2012 May 01; 36(5):427-32. PubMed ID: 21864295
    [Abstract] [Full Text] [Related]

  • 5. Promoter methylation and expression of DNA repair genes hMLH1 and MGMT in acute myeloid leukemia.
    Lenz G, Hutter G, Hiddemann W, Dreyling M.
    Ann Hematol; 2004 Oct 01; 83(10):628-33. PubMed ID: 15309527
    [Abstract] [Full Text] [Related]

  • 6. Concurrent hypermethylation of gene promoters is associated with a MSI-H phenotype and diploidy in gastric carcinomas.
    Carvalho B, Pinto M, Cirnes L, Oliveira C, Machado JC, Suriano G, Hamelin R, Carneiro F, Seruca R.
    Eur J Cancer; 2003 Jun 01; 39(9):1222-7. PubMed ID: 12763209
    [Abstract] [Full Text] [Related]

  • 7. Combined loss of expression of O6-methylguanine-DNA methyltransferase and hMLH1 accelerates progression of hepatocellular carcinoma.
    Matsukura S, Miyazaki K, Yakushiji H, Ogawa A, Chen Y, Sekiguchi M.
    J Surg Oncol; 2003 Mar 01; 82(3):194-200. PubMed ID: 12619064
    [Abstract] [Full Text] [Related]

  • 8. Silencing of O6-methylguanine DNA methyltransferase in the absence of promoter hypermethylation in hepatocellular carcinomas from Australia and South Africa.
    Herath NI, Walsh MD, Kew M, Smith JL, Jass JR, Young J, Leggett BA, Macdonald GA.
    Oncol Rep; 2007 Apr 01; 17(4):817-22. PubMed ID: 17342321
    [Abstract] [Full Text] [Related]

  • 9. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas.
    Ye C, Shrubsole MJ, Cai Q, Ness R, Grady WM, Smalley W, Cai H, Washington K, Zheng W.
    Oncol Rep; 2006 Aug 01; 16(2):429-35. PubMed ID: 16820927
    [Abstract] [Full Text] [Related]

  • 10. DNA hypermethylation status of multiple genes in soft tissue sarcomas.
    Kawaguchi K, Oda Y, Saito T, Yamamoto H, Takahira T, Kobayashi C, Tamiya S, Tateishi N, Iwamoto Y, Tsuneyoshi M.
    Mod Pathol; 2006 Jan 01; 19(1):106-14. PubMed ID: 16258501
    [Abstract] [Full Text] [Related]

  • 11. Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence.
    Lee KH, Lee JS, Nam JH, Choi C, Lee MC, Park CS, Juhng SW, Lee JH.
    Langenbecks Arch Surg; 2011 Oct 01; 396(7):1017-26. PubMed ID: 21706233
    [Abstract] [Full Text] [Related]

  • 12. Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma.
    Viswanathan M, Tsuchida N, Shanmugam G.
    Int J Cancer; 2003 May 20; 105(1):41-6. PubMed ID: 12672028
    [Abstract] [Full Text] [Related]

  • 13. hMLH1 and MGMT inactivation as a mechanism of tumorigenesis in monoclonal gammopathies.
    Martin P, Santón A, García-Cosio M, Bellas C.
    Mod Pathol; 2006 Jul 20; 19(7):914-21. PubMed ID: 16607377
    [Abstract] [Full Text] [Related]

  • 14. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relationship to aflatoxin B1-DNA adducts and p53 mutation in hepatocellular carcinoma.
    Zhang YJ, Chen Y, Ahsan H, Lunn RM, Lee PH, Chen CJ, Santella RM.
    Int J Cancer; 2003 Feb 10; 103(4):440-4. PubMed ID: 12478658
    [Abstract] [Full Text] [Related]

  • 15. Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma.
    Puri SK, Si L, Fan CY, Hanna E.
    Am J Otolaryngol; 2005 Feb 10; 26(1):12-7. PubMed ID: 15635575
    [Abstract] [Full Text] [Related]

  • 16. [Methylation pattern of DNA repair genes and microsatellite instability in hepatocelluar carcinoma].
    Park JH, Cho SB, Lee WS, Park CH, Joo YE, Kim HS, Choi SK, Rew JS, Lee JH, Kim SJ.
    Korean J Gastroenterol; 2006 Nov 10; 48(5):327-36. PubMed ID: 17132921
    [Abstract] [Full Text] [Related]

  • 17. Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability.
    Kim H, Kim YH, Kim SE, Kim NG, Noh SH, Kim H.
    J Pathol; 2003 May 10; 200(1):23-31. PubMed ID: 12692837
    [Abstract] [Full Text] [Related]

  • 18. Aberrant methylation of different DNA repair genes demonstrates distinct prognostic value for esophageal cancer.
    Ling ZQ, Li P, Ge MH, Hu FJ, Fang XH, Dong ZM, Mao WM.
    Dig Dis Sci; 2011 Oct 10; 56(10):2992-3004. PubMed ID: 21674174
    [Abstract] [Full Text] [Related]

  • 19. Promoter methylation status of MGMT, hMSH2, and hMLH1 and its relationship to corresponding protein expression and TP53 mutations in human esophageal squamous cell carcinoma.
    Su Y, Yin L, Liu R, Sheng J, Yang M, Wang Y, Pan E, Guo W, Pu Y, Zhang J, Liang G.
    Med Oncol; 2014 Feb 10; 31(2):784. PubMed ID: 24366688
    [Abstract] [Full Text] [Related]

  • 20. Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas.
    Psofaki V, Kalogera C, Tzambouras N, Stephanou D, Tsianos E, Seferiadis K, Kolios G.
    World J Gastroenterol; 2010 Jul 28; 16(28):3553-60. PubMed ID: 20653064
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.